Truly an inspiring experience at European Pancreatic Club EPC 2025 in Düsseldorf, Germany
04/07/2025
An inspiring gathering of the pancreatic community, sharing the latest research, updates, and critical discussions around improving care in pancreatic cancer and pancreatic surgery.
Many valuable sessions shared the latest updates and results from impactful clinical trials, advancing both the healthcare community and patient outcomes.
A big thank you to all the experts, surgeons, and partners who stopped by our booth; your engagement made for truly impactful conversations.
During the European Pancreatic Club EPC2025 in Düsseldorf, the Pancreatic Cancer Europe (PCE) team and our Magle PharmaCept team had a fruitful discussion about our ongoing partnership aimed at improving patient outcomes.
A session hosted by PCE shed light on the challenges of translating laboratory breakthroughs into effective treatments, emphasizing the critical steps needed to enhance outcomes for those affected by pancreatic cancer.
Our team actively participated in impactful discussions and attended several key sessions on pancreatic care and surgery. Here are some valuable insights that stood out:
• Innovative Surgery Techniques: Advanced procedures like the “triangle operation” are improving tumor removal and patient outcomes.
• Advanced Technology: Robotics, augmented reality, and intraoperative detection tools are enhancing surgical precision.
• Digital Analytics: New digital tools are enabling better patient monitoring and follow-up.
• Quality of Care: Centralizing pancreatic surgery in specialized centers ensures higher safety and treatment standards.
• Treatment Integration: Ongoing research is helping to define the optimal timing of surgery within chemotherapy protocols, especially for advanced pancreatic cancer.
These developments are shaping the future of pancreatic care and improving patient outcomes.
